RSPH Among Equal Weight ETFs
End-of-day Nov 19, 2026 · 21 Equal weight ETFs by 1W
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −4.3% | −0.7% | +3.7% | +23.5% | +27.1% | +50.0% | +32.5% | +179.4% | +781.1% |
| Peer average | −1.9% | −4.5% | −3.7% | −5.9% | +9.1% | +12.9% | +47.9% | +40.4% | +196.2% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$22 of every $1,000 in RSPH is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 2.20% | $220.17 | 116K | $22.8M |
| 2 | IDXXIDEXX Laboratories | Healthcare | 2.06% | $206.06 | 31K | $21.4M |
| 3 | MTDMettler-Toledo International | Healthcare | 2.05% | $205.41 | 12K | $21.3M |
| 4 | GEHCGE HealthCare Technologies | Healthcare | 1.94% | $194.49 | 241K | $20.2M |
| 5 | RVTYRevvity | Healthcare | 1.87% | $186.60 | 127K | $19.4M |
| 6 | VTRSViatris | Healthcare | 1.86% | $186.38 | 953K | $19.3M |
| 7 | AAgilent Technologies | Healthcare | 1.86% | $185.83 | 109K | $19.3M |
| 8 | EWEdwards Lifesciences | Healthcare | 1.85% | $185.09 | 182K | $19.2M |
| 9 | LLYEli Lilly | Healthcare | 1.85% | $184.95 | 14K | $19.2M |
| 10 | MCKMcKesson | Healthcare | 1.85% | $184.82 | 18K | $19.2M |
| 11 | STESteris | Healthcare | 1.83% | $182.71 | 73K | $18.9M |
| 12 | BDXBecton Dickinson | Healthcare | 1.82% | $182.41 | 88K | $18.9M |
| 13 | WSTWest Pharmaceutical Services | Healthcare | 1.82% | $181.85 | 47K | $18.9M |
| 14 | CRLCharles River Laboratories International | Healthcare | 1.82% | $181.58 | 57K | $18.8M |
| 15 | BIIBBiogen | Healthcare | 1.81% | $180.92 | 75K | $18.8M |
of the $18.8B in 21 Equal weight ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 2.20% |
| 2 | IDXX | IDEXX Laboratories | 2.06% |
| 3 | MTD | Mettler-Toledo International | 2.05% |
| 4 | GEHC | GE HealthCare Technologies | 1.94% |
| 5 | RVTY | Revvity | 1.87% |
| 6 | VTRS | Viatris | 1.86% |
| 7 | A | Agilent Technologies | 1.86% |
| 8 | EW | Edwards Lifesciences | 1.85% |
| 9 | LLY | Eli Lilly & | 1.85% |
| 10 | MCK | McKesson | 1.85% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0516 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0627 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0561 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0530 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0599 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0555 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0551 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0569 |
| Sep 23, 2024 | Sep 27, 2024 | $0.0547 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0508 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0459 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0499 |